76 related articles for article (PubMed ID: 15500163)
21. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
22. Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis?
Wenger M; Calamia KT; Salvarani C; Moncayo R; Schirmer M
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S1-2. PubMed ID: 14740421
[No Abstract] [Full Text] [Related]
23. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Koga S; Nakano S; Honma Y; Ogasawara N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
[No Abstract] [Full Text] [Related]
24. Increased glucose uptake by seborrheic keratosis detected by positron emission tomography.
Ibusuki A; Higashi Y; Kanekura T
J Dermatol; 2011 Jan; 38(1):104-5. PubMed ID: 21175767
[No Abstract] [Full Text] [Related]
25. The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Yoshida Y; Kurokawa T; Sawamura Y; Shinagawa A; Okazawa H; Fujibayashi Y; Kotsuji F
Gynecol Oncol; 2007 Mar; 104(3):764-6. PubMed ID: 17156828
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of 18F-FDG-PET in breast cancer imaging].
Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
[No Abstract] [Full Text] [Related]
27. PET imaging I.
Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):xi-xiii. PubMed ID: 15488552
[No Abstract] [Full Text] [Related]
28. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
Tahara N; Kai H; Nakaura H; Mizoguchi M; Ishibashi M; Kaida H; Baba K; Hayabuchi N; Imaizumi T
Eur Heart J; 2007 Sep; 28(18):2243-8. PubMed ID: 17681956
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG-positron emission tomography for diagnosis of large vessel arteritis in Behçet's disease.
Wenger M; Baltaci M; Klein-Weigel P; Donnemiller E; Moncayo R; Schirmer M
Adv Exp Med Biol; 2003; 528():435-6. PubMed ID: 12918739
[No Abstract] [Full Text] [Related]
30. [Fluorine-18 in radiopharmacy].
de Beco V; Le Bars D; Scherrmann JM
Ann Pharm Fr; 2008 Jan; 66(1):60-5. PubMed ID: 18435989
[TBL] [Abstract][Full Text] [Related]
31. Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography.
Meave A; Soto ME; Reyes PA; Cruz P; Talayero JA; Sierra C; Alexanderson E
Tex Heart Inst J; 2007; 34(4):466-9. PubMed ID: 18172533
[TBL] [Abstract][Full Text] [Related]
32. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries.
Brodmann M; Lipp RW; Passath A; Seinost G; Pabst E; Pilger E
Rheumatology (Oxford); 2004 Feb; 43(2):241-2. PubMed ID: 13130153
[TBL] [Abstract][Full Text] [Related]
33. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
Basu S; Rao R
J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
[No Abstract] [Full Text] [Related]
34. [Clinical application of positron emission tomography and 18FDG to brain tumor].
Momose T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
[No Abstract] [Full Text] [Related]
35. Clinical image: occult large vessel vasculitis diagnosed by PET imaging.
Wiest R; Glück T; Schönberger J; Schölmerich J; Eilles C; Müller-Ladner U
Rheumatol Int; 2001 Aug; 20(6):250. PubMed ID: 11563586
[No Abstract] [Full Text] [Related]
36. [Early prediction of response to primary chemotherapy by sequential FDG -PET in patients with advanced breast cancer].
Momiyama N; Ishikawa T; Ichikawa Y; Shimada H; Katayama A; Ozawa Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():385-8. PubMed ID: 17679210
[No Abstract] [Full Text] [Related]
37. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Masada T; Matsumoto Y; Kawai N; Tamiya T; Nagao S
No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
[TBL] [Abstract][Full Text] [Related]
38. [18FDG PET: a new criterion for disease activity in Takayasu arteritis].
Lavogiez C; Quéméneur T; Hachulla E; Huglo D; Launay D; Lambert M; Queyrel V; Hatron PY; Steinling M
Rev Med Interne; 2006 Jun; 27(6):478-81. PubMed ID: 16563574
[TBL] [Abstract][Full Text] [Related]
39. Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging.
Tawakol A; Singh P; Rudd JH; Soffer J; Cai G; Vucic E; Brannan SP; Tarka EA; Shaddinger BC; Sarov-Blat L; Matthews P; Subramanian S; Farkouh M; Fayad ZA
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):86-8. PubMed ID: 23973698
[No Abstract] [Full Text] [Related]
40. Cardiac structural abnormalities associated with IgG4-related coronary periarteritis and inflammation revealed by multimodality imaging.
Tong AK; Tan SY; Go YY; Lam WW
Can J Cardiol; 2014 Aug; 30(8):956.e15-7. PubMed ID: 24951253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
